Study summary

Osimertinib before surgery shrank tumors far more than chemotherapy alone

NeoADAURA trial (osimertinib before surgery) · 358 people, phase 3 · Published September 2025, Journal of Clinical Oncology

26%major pathologic response with osimertinib plus chemo, vs 2% with chemo

What was tested

Osimertinib with or without chemotherapy, or chemotherapy alone, before surgery for resectable stage II to IIIB EGFR-mutated lung cancer.

What they found

What it means

Supports giving osimertinib before surgery; long-term survival results are still to come.

J Clin Oncol, via PubMed ↗ Trial record NCT04351555 ↗ ← Back to the outlook
Last reviewed 2026-11-16 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.